For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Fate Therapeutics Inc (NASDAQ: FATE) was $0.94 for the day, down -0.21% from the previous closing price of $0.94. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 1.42 million shares were traded. FATE stock price reached its highest trading level at $0.9695 during the session, while it also had its lowest trading level at $0.9102.
Ratios:
Our analysis of FATE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.58 and its Current Ratio is at 7.58. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’25 when Wolchko J Scott bought 113,178 shares for $0.93 per share.
Bressi Jerome Charles sold 5,980 shares of FATE for $9,269 on Jan 10 ’25. The insider now owns 270,203 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the insider of the company, sold 5,654 shares for $1.55 each. As a result, the insider received 8,764 and left with 336,707 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 107893080 and an Enterprise Value of -85906528. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.92 while its Price-to-Book (P/B) ratio in mrq is 0.34. Its current Enterprise Value per Revenue stands at -6.302 whereas that against EBITDA is 0.487.
Stock Price History:
The Beta on a monthly basis for FATE is 2.32, which has changed by -0.86647725 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $7.70, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -27.92%, while the 200-Day Moving Average is calculated to be -66.21%.
Shares Statistics:
FATE traded an average of 2.73M shares per day over the past three months and 2527130 shares per day over the past ten days. A total of 113.93M shares are outstanding, with a floating share count of 98.49M. Insiders hold about 14.06% of the company’s shares, while institutions hold 80.81% stake in the company. Shares short for FATE as of 1740700800 were 13328335 with a Short Ratio of 4.88, compared to 1738281600 on 12869655. Therefore, it implies a Short% of Shares Outstanding of 13328335 and a Short% of Float of 13.33.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
